Progress in the Application of the Residual SYNTAX Score and Its Derived Scores.

Xinjun Lin, Zhibin Mei, Wei Ji, Yaoguo Wang, Chaoxiang Xu

Abstract readReview

In one paragraph

Review in Reviews in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xinjun LinThe Second Clinical College of Fujian Medical University, 362000 Quanzhou, Fujian, China.

Zhibin MeiThe Second Clinical College of Fujian Medical University, 362000 Quanzhou, Fujian, China.

Wei JiThe Second Clinical College of Fujian Medical University, 362000 Quanzhou, Fujian, China.

Yaoguo WangDepartment of Cardiology, the Second Affiliated Hospital of Fujian Medical University, 362000 Quanzhou, Fujian, China.

Chaoxiang XuDepartment of Cardiology, the Second Affiliated Hospital of Fujian Medical University, 362000 Quanzhou, Fujian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The residual SYNTAX score (rSS) is employed for the quantification of residual coronary lesions and to guide revascularization. rSS can be combined with other examinations to evaluate the severity of vascular disease and play an evaluative and guiding role in various scenarios. Furthermore, combining rSS with other indicators, benefits prognosis evaluation, and rSS-derived scores have been increasingly used in clinical practice. This article reviews the progress in the clinical application of rSS and its derived scores for complex coronary arteries and other aspects, based on relevant literature.

Indexed as

coronary artery diseaseprognosisrational revascularizationresidual functional SYNTAX scoreresidual SYNTAX score

Identifiers

PMID39076942

DOI10.31083/j.rcm2503080

PMCPMC11263829

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.